Another interesting example is that of the gene SHANK3: mutations in this gene lead to a neurodevelopmental disorder known as Phelan-McDermid syndrome; to date, no pharmaceutical compounds targeting core symptoms of this human disease are available. The gene discussed is SHANK3; the disease is Phelan-McDermid syndrome.